Cerebral microvascular pathology in aging and Alzheimer's disease
Open accessThe DOI matches its Crossref record; 289 of the 292 references it cites were found in a registry or an index.
Abstract
The aging of the central nervous system and the development of incapacitating neurological diseases like Alzheimer's disease (AD) are generally associated with a wide range of histological and pathophysiological changes eventually leading to a compromised cognitive status. Although the diverse triggers of the neurodegenerative processes and their interactions are still the topic of extensive debate, the possible contribution of cerebrovascular deficiencies has been vigorously promoted in recent years. Various forms of cerebrovascular insufficiency such as reduced blood supply to the brain or disrupted microvascular integrity in cortical regions may occupy an initiating or intermediate position in the chain of events ending with cognitive failure. When, for example, vasoconstriction takes over a dominating role in the cerebral vessels, the perfusion rate of the brain can considerably decrease causing directly or through structural vascular damage a drop in cerebral glucose utilization. Consequently, cerebral metabolism can suffer a setback leading to neuronal damage and a concomitant suboptimal cognitive capacity. The present review focuses on the microvascular aspects of neurodegenerative processes in aging and AD with special attention to cerebral blood flow, neural metabolic changes and the abnormalities in microvascular ultrastructure. In this context, a few of the specific triggers leading to the prominent cerebrovascular pathology, as well as the potential neurological outcome of the compromised cerebral microvascular system are also going to be touched upon to a certain extent, without aiming at total comprehensiveness. Finally, a set of animal models are going to be presented that are frequently used to uncover the functional relationship between cerebrovascular factors and the damage to neural networks.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Hypertension in mice lacking the gene for endothelial nitric oxide synthase
Huang, P. L., Huang, Z., Mashimo, H., Bloch, K. D., Moskowitz, M. A., Bevan, J. A., & Fishman, M. C. (1995) · Nature · doi:10.1038/377239a0 · Cited by 2,070 · cited 4×
“With the help of these models, it was shown that eNOS mediated basal vasodilatation (Huang et al., 1995) and that endothelial NO could buffer blood pressure variability (Strauss et al.”
BackgroundMethodInfluential15-year longitudinal study of blood pressure and dementia
Skoog, I., Nilsson, L., Persson, G., Lernfelt, B., Landahl, S., Palmertz, B., Andreasson, L.-A., Odén, A., & Svanborg, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90608-x · Cited by 1,726 · cited 2×
“Epidemiological studies emphasized the role of peripheral vascular abnormalities like atherosclerosis or hypertension as risk factors aggravating the progression of cognitive decline (Skoog et al., 1996; Skoog, 1997; Hofman et al., 1997; Breteler, 2000), and a further link has been suggested between the systemic and n…”
BackgroundPaulson, O. B., Strandgaard, S., & Edvinsson, L. (1990) · PubMed · Cited by 1,111
CEREBRAL BLOOD FLOW, BLOOD VOLUME AND OXYGEN UTILIZATION: NORMAL VALUES AND EFFECT OF AGE
LEENDERS, K. L., PERANI, D., LAMMERTSMA, A. A., HEATHER, J. D., BUCKINGHAM, P., JONES, T., HEALY, M. J. R., GIBBS, J. M., WISE, R. J. S., HATAZAWA, J., et al. (1990) · Brain · doi:10.1093/brain/113.1.27 · Cited by 1,093 · cited 8×
“Since the brain’s fundamental energy source is glucose and its metabolism requires oxygen, the coupling of cerebral glucose utilization (CGU) and cerebral metabolic rate for oxygen (CMRO2) with CBF has been widely investigated in physiological conditions, as well as in neurodegenerative diseases.”
BackgroundInfluentialCerebral amyloid angiopathy. A critical review.
Vinters, H. V. (1987) · Stroke · doi:10.1161/01.str.18.2.311 · Cited by 1,071 · cited 1×
“…the extracranial vessels supplying the brain (Kalaria, 1996; Hofman et al., 1997; Breteler, 2000) or amyloid angiopathy in mid-size brain arteries (Vinters, 1987; Coria and Rubio, 1996; Opeskin, 1996) not only physically thicken the vascular wall, but also contribute to marked blood flow…”
BackgroundHofman, A., Ott, A., Breteler, M. M., Bots, M. L., Slooter, A. J., van Harskamp, F., van Duijn, C. N., Van Broeckhoven, C., & Grobbee, D. E. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09328-2 · Cited by 1,062 · cited 6×
“Atherosclerosis in the extracranial vessels supplying the brain (Kalaria, 1996; Hofman et al., 1997; Breteler, 2000) or amyloid angiopathy in mid-size brain arteries (Vinters, 1987; Coria and Rubio, 1996; Opeskin, 1996) not only physically thicken the vascular wall, but also contribute to marked blood flow disturbance…”
BackgroundInfluentialTHE CELL BIOLOGY OF THE BLOOD-BRAIN BARRIER
Rubin, L. L., & Staddon, J. M. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.11 · Cited by 1,000 · cited 1×
“The tight junctions seal the space between the meeting endothelial surfaces and are considered as the morphological basis for the BBB gaining their full functional integrity with the maturation of the animal (Rubin and Staddon, 1999; Kniesel and Wolburg, 2000; Saunders et al., 2000).”
BackgroundPericytes in the microvasculature
Hirschi, K. (1996) · Cardiovascular Research · doi:10.1016/0008-6363(96)00063-6 · Cited by 775 · cited 1×
“Furthermore, the pericytes can contribute to the regulation of vascular development by inhibiting endothelial cell proliferation and differentiation via chemical signaling (Shepro and Morel, 1993; Hirschi and D’Amore, 1996; Balabanov and Dore-Duffy, 1998; Martin et al., 2000; Rucker et al., 2000).”
BackgroundOxidative Stress in Brain Ischemia
Love, S. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00214.x · Cited by 685 · cited 2×
“The calcium-generated synthesis and accumulation of the easily translocating NO and its toxic products (Beckman, 1991; Love, 1999) can attack the integrity of the BBB: it may cause astrocytic dysfunction (Schubert et al.”
BackgroundWeller, R. O., Massey, A., Newman, T. A., Hutchings, M., Kuo, Y.-M., & Roher, A. E. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65616-7 · Cited by 679
Cited by
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
“…fewer intact branches, atrophic string vessels, increased irregularity of capillary surfaces, marked changes in the vessel diameter, capillary basement membrane thickening, and collagen accumulation in the basement membrane have been described in AD (Farkas and Luiten, 2001; Bailey et al., 2004).”
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
“These changes include the appearance of string vessels (collapsed and acellular membrane tubes), a reduction in capillary density, a rise in endothelial pinocytosis , a decrease in mitochondrial content, accumulation of collagen and perlecans in the basement membrane, loss of tight junctions and/or adherens junction”
Background
Metadata
- Authors
- Farkas, E., & Luiten, P. G. M.
- Affiliations
- University of Groningen (NL)
- Corresponding author
- Farkas, Eszter
- ORCID
- Farkas, Eszter
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2001-08
- Volume
- 64
- Issue
- 6
- Pages
- 575-611
- ISSN
- 0301-0082 (ISSN-L)
- OpenAlex
- W2073748140
- Cited by
- 1,102
- References
- 292
- Citations by year
- 2026: 17 · 2025: 35 · 2024: 27 · 2023: 30 · 2022: 51 · 2021: 55 · 2020: 49 · 2019: 70 · 2018: 53 · 2017: 57 · 2016: 59 · 2015: 61 · 2014: 66 · 2013: 48 · 2012: 44
- FWCI
- 2.64
- Type
- journal article
- Language
- en
- Open access
- green
- research.rug.nl
- Licence
- other-oa
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Progress in Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Topics
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- cerebral microvasculature, Alzheimer's disease, brain aging, cerebrovascular insufficiency, cerebral blood flow, brain glucose metabolism, vasoconstriction, neurodegeneration, animal models of Alzheimer's disease
- MeSH terms
- Aging, Alzheimer Disease, Animals, Basement Membrane, Blood-Brain Barrier, Brain, Capillaries, Cerebrovascular Circulation, Cholinergic Fibers, Cognition, Humans, Learning, Microcirculation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cerebral microvascular pathology in aging and Alzheimer's disease. https://app.cochat.ai/papers/10.1016/s0301-0082(00)00068-x
- The paper
- Farkas, E., & Luiten, P. G. M. (2001). Cerebral microvascular pathology in aging and Alzheimer's disease. Progress in Neurobiology. https://doi.org/10.1016/s0301-0082(00)00068-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.